Pharma and biotech companies: Don’t just merge, innovate

By Patrick Skerrett @PJSkerrett

April 20, 2016

APStock

Editor’s note: This article was mistakenly published. It has been removed from the website.

About the Author

Patrick Skerrett

Editor, First Opinion

Patrick Skerrett edits First Opinion, STAT's perspective and opinion section.

patrick.skerrett@statnews.com

Tags

pharmaceutical industry

Leave a Comment Cancel reply

Recommended

Fighter cockpit

Using Air Force ‘boldface’ to ease the opioid crisis

Using Air Force ‘boldface’ to ease the opioid crisis

Immunotherapy scans

Combination immunotherapy may have failed in the Incyte/Merck trial,…

Combination immunotherapy may have failed in the Incyte/Merck trial, but it’s here to stay

Donald Trump April 2018

On drug pricing, Trump could rely on bluster and…

On drug pricing, Trump could rely on bluster and bad ideas. But there’s a better alternative

Recommended Stories

Immunotherapy scans

First Opinion

Combination immunotherapy may have failed in the Incyte/Merck trial, but it’s here to stay

By Raymond J. Tesi

Fighter cockpit

First Opinion

Using Air Force ‘boldface’ to ease the opioid crisis

By Jim Huizenga

advertisement

Donald Trump April 2018

First Opinion

On drug pricing, Trump could rely on bluster and bad ideas. But there’s a better alternative

By David Beier and John Osborn

Politics

Experts debate: How tightly should e-cigarettes be regulated?

By Patrick Skerrett

Laennec's stethoscope

First Opinion

Artificial intelligence will put a premium on physicians’ knowledge and decision-making skills

By Marschall S. Runge